Basic Information
Basic information for SNHG17-233-25aa-2
Peptide Name SNHG17-233-25aa-2
Genome Position chr20:38422007-38422081[-]
Species Human
Peptide Sequence MEKVAGGARKAVFLWITLAGHLPRL
Peptide Length 25
Unique No (SNHG17-202-25aa-2,SNHG17-224-25aa-1,SNHG17-230-25aa-1,SNHG17-231-25aa-2,SNHG17-258-25aa-1,SNHG17-267-25aa-2,SNHG17-272-25aa-1,SNHG17-274-25aa-1,SNHG17-278-25aa-2,SNHG17-280-25aa-2,SNHG17-284-25aa-3)
Grand Average of Hydropathicity 0.484
Relative Molecular Mass 3167.7
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000658141;SNHG17-233
Transcript Length 1882
Coding Ability 0.4299
DNA Sequence Corresponding to Peptide ATGGAGAAAGTTGCAGGTGGGGCTAGGAAAGCTGTATTCCTGTGGATTACTCTAGCTGGTCATTTGCCCCGATTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :